Alexandre Theocharides

2.8k total citations
42 papers, 1.7k citations indexed

About

Alexandre Theocharides is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Alexandre Theocharides has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 18 papers in Hematology and 17 papers in Molecular Biology. Recurrent topics in Alexandre Theocharides's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Acute Myeloid Leukemia Research (10 papers) and Eosinophilic Disorders and Syndromes (8 papers). Alexandre Theocharides is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Acute Myeloid Leukemia Research (10 papers) and Eosinophilic Disorders and Syndromes (8 papers). Alexandre Theocharides collaborates with scholars based in Switzerland, United States and United Kingdom. Alexandre Theocharides's co-authors include Radek C. Skoda, André Tichelli, Sai Li, Róbert Královics, Markus G. Manz, Soon-Siong Teo, Andreas Buser, Richard A. Flavell, Heinz Gisslinger and Anthony Rongvaux and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Alexandre Theocharides

41 papers receiving 1.7k citations

Peers

Countries citing papers authored by Alexandre Theocharides

Since Specialization

Citations

This map shows the geographic impact of Alexandre Theocharides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Theocharides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Theocharides more than expected).

Fields of papers citing papers by Alexandre Theocharides

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Theocharides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Theocharides. The network helps show where Alexandre Theocharides may publish in the future.

Co-authorship network of co-authors of Alexandre Theocharides

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Theocharides. A scholar is included among the top collaborators of Alexandre Theocharides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Theocharides. Alexandre Theocharides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes 2025 ·Frontiers in Oncology ·(unknown), Kristin Stirm, Veronika Lysenko, Corina Schneidawind, Alexandar Tzankov, Anne Müller, Alexandre Theocharides	0
2	Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells 2024 ·EMBO Molecular Medicine ·Jan Mueller, (unknown), Christian Koch, Florin Schneiter, (unknown), Veronika Lysenko, Christian Pellegrino, (unknown), Norman F. Russkamp, Renier Myburgh, (unknown), Alexandre Theocharides, Kari J. Kurppa, Benjamin L. Ebert, Timm Schroeder, Markus G. Manz, Steffen Boettcher	16
3	Bone marrow haematopoiesis in patients with COVID‐19 2023 ·Histopathology ·(unknown), (unknown), (unknown), (unknown), Nathalie Schwab, Angela Frank, Baptiste Hamelin, Zsuzsanna Varga, César Nombela‐Arrieta, Kirsten D. Mertz, Alexandre Theocharides, Viktor H. Koelzer	1
4	Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model 2023 ·Leukemia ·Veronika Lysenko, (unknown), Selma Tuzlak, (unknown), Larisa V. Kovtonyuk, Burkhard Becher, Markus G. Manz, Stefanie Kreutmair, Alexandre Theocharides	9
5	PARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapy 2023 ·Cell Reports Medicine ·(unknown), (unknown), (unknown), Katja Seipel, (unknown), Peter J.M. Valk, Alexandre Theocharides, François Mercier, Thomas Pabst, Maureen McKeague, Nathan W. Luedtke	7
6	Calreticulin mutations affect its chaperone function and perturb the glycoproteome 2022 ·Cell Reports ·(unknown), Liliana Malinovska, (unknown), Marco Losa, (unknown), Mattheus H. E. Wildschut, Veronika Lysenko, Asvin KK Lakkaraju, Christina A. Maat, Dietmar Benke, Adriano Aguzzi, Bernd Wollscheid, Paola Picotti, Alexandre Theocharides	11
7	Proteomic identification of proliferation and progression markers in human polycythemia vera stem and progenitor cells 2022 ·Blood Advances ·Ge Tan, Witold Wolski, (unknown), (unknown), Alexandre Theocharides, Markus G. Manz, Ruedi Aebersold, Fabienne Meier‐Abt	2
8	Disruption of CSF-1R signaling inhibits growth of AML with inv(16) 2021 ·Blood Advances ·Alexander Simonis, Norman F. Russkamp, Jan Mueller, C. Matthias Wilk, Mattheus H. E. Wildschut, Renier Myburgh, (unknown), (unknown), Stefan Balabanov, Peter J.M. Valk, Alexandre Theocharides, Markus G. Manz	7
9	Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria 2021 ·Cell chemical biology ·François Halloy, Pavithra S. Iyer, Alice Ghidini, Veronika Lysenko, Jasmin Barman‐Aksözen, (unknown), (unknown), (unknown), Marc‐David Ruepp, Elisabeth I. Minder, (unknown), Xiaoye Schneider‐Yin, Alexandre Theocharides, Daniel Schümperli, Jonathan Hall	15
10	Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria 2020 ·Nucleic Acids Research ·François Halloy, Pavithra S. Iyer, (unknown), Alice Ghidini, Jasmin Barman‐Aksözen, (unknown), Alexandre Theocharides, Elisabeth I. Minder, Xiaoye Schneider‐Yin, Daniel Schümperli, Jonathan Hall	22
11	The IL ‐6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B‐cell lymphoma 2019 ·EMBO Molecular Medicine ·(unknown), Katrin Bertram, Kristin Stirm, (unknown), (unknown), (unknown), Markus G. Manz, Alexandre Theocharides, Alexandar Tzankov, Anne Müller	47
12	Candida albicans-Induced NETosis Is Independent of Peptidylarginine Deiminase 4 2018 ·Frontiers in Immunology ·Eva Guiducci, (unknown), (unknown), Elisabeth M. Schraner, Alexandre Theocharides, Salomé LeibundGut‐Landmann	85
13	The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14 2018 ·Haematologica ·Beatrice Drexler, Jakob Passweg, Alexandar Tzankov, (unknown), Alexandre Theocharides, Nathan Cantoni, Peter M. Keller, Georg Stüssi, (unknown), Rudolf Benz, (unknown), Pontus Lundberg, Ronny Nienhold, Andrea Fuhrer, Christine Biaggi, Markus G. Manz, Mario Bargetzi, Simón Méndez‐Ferrer, Radek C. Skoda	23
14	IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms 2015 ·Journal of Clinical Investigation ·Lukas F. Mager, Carsten Riether, Christian M. Schürch, Yara Banz, Marie-Hélène Wasmer, (unknown), Alexandre Theocharides, Xiaohong Li, Yu Xia, Hirohisa Saito, Susumu Nakae, Gabriela M. Baerlocher, Markus G. Manz, Kathy D. McCoy, Andrew J. Macpherson, Adrian F. Ochsenbein, Bruce Beutler, Philippe Krebs	73
15	Humanized hemato-lymphoid system mice 2015 ·Haematologica ·Alexandre Theocharides, Anthony Rongvaux, Kelly Fritsch, Richard A. Flavell, Markus G. Manz	131
16	Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts 2014 ·Leukemia ·Alexandre Theocharides, Stephanie M. Dobson, Elisa Laurenti, Faiyaz Notta, Véronique Voisin, (unknown), Julie S. Yuan, Cynthia J. Guidos, Mark D. Minden, Charles G. Mullighan, Emina Torlakovic, John E. Dick	23
17	Angiogenesis and vascular endothelial growth factor‐/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2‐V617F mutational status 2009 ·British Journal of Haematology ·Michael Medinger, Radek C. Skoda, Aloïs Gratwohl, Alexandre Theocharides, Andreas Buser, Dominik Heim, Stephan Dirnhofer, André Tichelli, Alexandar Tzankov	66
18	The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders 2008 ·Haematologica ·Alexandre Theocharides, Jakob Passweg, Michael Medinger, (unknown), Shifang Li, Hui Hao-Shen, Andreas Buser, Aloïs Gratwohl, André Tichelli, Radek C. Skoda	30
19	Patient and product factors affecting platelet transfusion results 2008 ·Transfusion ·Dominik Heim, Jakob Passweg, Michael Gregor, Andreas Buser, Alexandre Theocharides, (unknown), Sandrine Meyer‐Monard, Jörg Halter, André Tichelli, Aloïs Gratwohl	33
20	Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3 2008 ·Journal of Clinical Pathology ·Alexandar Tzankov, (unknown), Dominique Mühlematter, Alexandre Theocharides, Philip Went, Martine Jotterand, H.‐P. Horny, S Dirnhofer	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact